BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35447518)

  • 1. Multifunctional "ball-rod" Janus nanoparticles boosting Fenton reaction for ferroptosis therapy of non-small cell lung cancer.
    Zhu G; Chi H; Liu M; Yin Y; Diao H; Liu Z; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K
    J Colloid Interface Sci; 2022 Sep; 621():12-23. PubMed ID: 35447518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Responsive multifunctional "core-shell" magnetic nanoparticles promoting Fenton reaction for tumor ferroptosis therapy.
    Chi H; Zhu G; Yin Y; Diao H; Liu Z; Sun S; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K
    Int J Pharm; 2022 Jun; 622():121898. PubMed ID: 35688287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
    Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
    Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.
    Liu T; Liu W; Zhang M; Yu W; Gao F; Li C; Wang SB; Feng J; Zhang XZ
    ACS Nano; 2018 Dec; 12(12):12181-12192. PubMed ID: 30458111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
    Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
    Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Au-Fe
    Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
    J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
    Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
    Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis.
    Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L
    J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Delivery of Theranostic Nanoclusters for Lung Cancer Ferroptosis with Enhanced Chemodynamic/Radiation Synergistic Therapy.
    Li Y; Yang J; Gu G; Guo X; He C; Sun J; Zou H; Wang H; Liu S; Li X; Zhang S; Wang K; Yang L; Jiang Y; Wu L; Sun X
    Nano Lett; 2022 Feb; 22(3):963-972. PubMed ID: 35073699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification.
    Zhou L; Chen J; Li R; Wei L; Xiong H; Wang C; Chai K; Chen M; Zhu Z; Yao T; Lin Y; Dong C; Shi S
    Small; 2021 Nov; 17(47):e2103919. PubMed ID: 34623753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
    Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
    Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
    Liu X; Zhu X; Qi X; Meng X; Xu K
    Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivalent Polypeptide and Tannic Acid Cooperatively Iron-Coordinated Nanohybrids for Synergistic Cancer Photothermal Ferroptosis Therapy.
    He M; Du C; Xia J; Zhang ZG; Dong CM
    Biomacromolecules; 2022 Jun; 23(6):2655-2666. PubMed ID: 35583462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy.
    Yu H; Yan J; Li Z; Song T; Ning F; Tan J; Sun Y
    J Mater Chem B; 2023 Jan; 11(2):415-429. PubMed ID: 36512437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Sensitive Molecular-Switch-Containing Polymer Nanoparticle for Breast Cancer Therapy with Ferritinophagy-Cascade Ferroptosis and Tumor Immune Activation.
    Zuo T; Fang T; Zhang J; Yang J; Xu R; Wang Z; Deng H; Shen Q
    Adv Healthc Mater; 2021 Nov; 10(21):e2100683. PubMed ID: 34535975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Immune Response for Colorectal Cancer Therapy Triggered by Multifunctional Nanocomposites with Self-Amplifying Antitumor Ferroptosis.
    Lin X; Chen H; Deng T; Cai B; Xia Y; Xie L; Wang H; Huang C
    ACS Appl Mater Interfaces; 2024 Mar; 16(11):13481-13495. PubMed ID: 38456402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification.
    Feng W; Shi W; Wang Z; Cui Y; Shao X; Liu S; Rong L; Liu Y; Zhang H
    ACS Appl Mater Interfaces; 2022 Aug; 14(33):37540-37552. PubMed ID: 35944147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
    An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
    Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
    J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
    Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.